CP3 Director Walid Gellad Talks to Politico about Drug Pricing Initiatives

August 3, 2018

"This is not the kind of structural change we want in the market so that prices go down,” notes CP3 Director Walid Gellad in a Politico piece about drug companies' recent initiatives to lower prices.  Gellad describes the concessions as a mix of potential positive and negative outcomes, echoing the response of analysts who are also watching these developments.